Unique ID issued by UMIN | UMIN000033748 |
---|---|
Receipt number | R000038489 |
Scientific Title | A study to evaluate effects of test food on physical performance and fatigue during exercise |
Date of disclosure of the study information | 2018/09/12 |
Last modified on | 2019/02/13 11:03:25 |
A study to evaluate effects of test food on physical performance and fatigue during exercise
A study to evaluate effects of test food on physical performance and fatigue during exercise
A study to evaluate effects of test food on physical performance and fatigue during exercise
A study to evaluate effects of test food on physical performance and fatigue during exercise
Japan |
Healthy adults
Adult |
Others
NO
To evaluate effects of test food on physical exercise and fatigue.
Efficacy
Maximal oxygen consumption (VO2 max)
Questionnaire on fatigue
Ventilation threshold
Rating of perceived exertion
Physical performance
Blood biochemistry
Muscle mass
Body fat mass
Intestinal microbiome
Interventional
Parallel
Randomized
Individual
Double blind -all involved are blinded
Placebo
3
Prevention
Food |
Intake 3 tablets of active food 1 daily for 9 weeks.
Intake 3 tablets of active food 2 daily for 9 weeks.
Intake 3 tablets of placebo food daily for 9 weeks.
20 | years-old | <= |
49 | years-old | >= |
Male
1)Males aged 20-49 years.
2)Subjects who have exercise habits once or twice a week.
3)Subjects who can continue with the exercise habits during test period.
4)Subjects who don't take prohibited foods such as dietary supplements for exercise and can keep it during test period.
5)Subjects who show understanding of the clinical study procedures and agreement with participating the study by written informed consent.
1)Subjects who have consciousness of being constipation or diarrhea.
2)Subjects who have previous and/or current medical history of serious disease in heart, liver, kidney, or digestive system.
3)Subjects who drink alcohol a lot.
4)Subjects who have extremely irregular dietary habits or life rhythm.
5)Subjects who have allergy to medicines or foods.
6)Subjects who are participating the other clinical test, were participating it within the past 4 weeks, or are going to participate it.
7)Subjects who donated blood over 200mL in the past 1 month or over 400mL in the past 3 months.
8)Subjects judged as unsuitable for the study by the principal or attending investigator.
36
1st name | |
Middle name | |
Last name | Suguru Fujiwara |
CPCC Company Limited
Clinical Research Planning Department
4F Chushin Building, 3-3-5 Uchikanda, Chiyoda-ku, Tokyo 101-0047, Japan
03-5297-3112
cpcc-contact@cpcc.co.jp
1st name | |
Middle name | |
Last name | Masanori Numa |
CPCC Company Limited
Plan Sales Department
4F Chushin Building, 3-3-5 Uchikanda, Chiyoda-ku, Tokyo 101-0047, Japan
03-5297-3112
cpcc-contact@cpcc.co.jp
CPCC Company Limited
Asahi Group Holdings, Ltd.
Profit organization
NO
2018 | Year | 09 | Month | 12 | Day |
Unpublished
Completed
2018 | Year | 08 | Month | 10 | Day |
2018 | Year | 09 | Month | 13 | Day |
2018 | Year | 08 | Month | 14 | Day |
2019 | Year | 02 | Month | 13 | Day |
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000038489